Atai Life Sciences Stock Analysis

ATAI Stock Analysis Notes

About 27.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.57. Some equities with similar Price to Book (P/B) outperform the market in the long run. ATAI Life Sciences recorded a loss per share of 0.8. The entity last dividend was issued on the 27th of August 2018. Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. For more info on ATAI Life Sciences please contact Florian Brand at 49 89 2153 9035 or go to https://www.atai.life.

ATAI Life Sciences Investment Alerts

ATAI Life Sciences Upcoming and Recent Events

ATAI Largest EPS Surprises

View All Earnings Estimates

ATAI Stock Institutional Investors

Note, although ATAI Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ATAI Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 228.21 M.

ATAI Profitablity

Management Efficiency

ATAI Life Sciences has return on total asset (ROA) of (0.2541) % which means that it has lost $0.2541 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6277) %, meaning that it created substantial loss on money invested by shareholders. ATAI Life's management efficiency ratios could be used to measure how well ATAI Life manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.14. The current Return On Capital Employed is estimated to decrease to -0.48. As of now, ATAI Life's Total Current Assets are increasing as compared to previous years. The ATAI Life's current Debt To Assets is estimated to increase to 0.06, while Total Assets are projected to decrease to under 261.1 M.

Technical Drivers

As of the 16th of December 2024, ATAI Life owns the coefficient of variation of 3122.48, and Market Risk Adjusted Performance of 0.0689. ATAI Life Sciences technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices.

ATAI Life Sciences Price Movement Analysis

ATAI Life Sciences Insider Trading Activities

ATAI Life Outstanding Bonds

ATAI Life Predictive Daily Indicators

ATAI Life Forecast Models

ATAI Life's time-series forecasting models are one of many ATAI Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ATAI Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ATAI Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ATAI shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ATAI Life. By using and applying ATAI Stock analysis, traders can create a robust methodology for identifying ATAI entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ATAI analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ATAI analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ATAI Life Sciences stock analysis indicators help investors evaluate how ATAI Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ATAI Life shares will generate the highest return on investment. By understating and applying ATAI Life stock analysis, traders can identify ATAI Life position entry and exit signals to maximize returns.

When running ATAI Life's price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.